Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures

NCT00143143 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00143143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2001
Completion date
February 28, 2006
Enrollment
300
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsies, partial, epilepsy, complex partial